NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹41 Cr | ₹20 Cr | ₹50 Cr | ₹57 Cr | ₹8.12 Cr |
What is the latest Consolidated Net Profit of NGL FINECHEM ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹41 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹50 Cr |
Mar2021 | ₹57 Cr |
Mar2020 | ₹8.12 Cr |
How is Consolidated Net Profit of NGL FINECHEM Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹41 Cr | 101.67 | |
Mar2023 | ₹20 Cr | -59.05 | |
Mar2022 | ₹50 Cr | -11.91 | |
Mar2021 | ₹57 Cr | 597.03 | |
Mar2020 | ₹8.12 Cr | - |
Compare Consolidated Net Profit of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹851.7 Cr | 5% | 37.2% | -48% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 5% |
37.2% |
-48% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses